Cyclacel amends stock purchase agreement with interim CEO for up to $8M equity line; adds 6-month lock-up

Bio Green Med Solution, Inc.

Purchase price amended to greater of closing bid at signing or prior to each purchase date.
Added 6-month lock-up on any Shares issued under the agreement.
Company retains right to direct David Lazar to buy up to $8,000,000 of common stock through Sep 30, 2026.
Shares issued in reliance on exemptions under Securities Act Section 4(a)(2) and Regulation S or D.
Lazar is interim CEO; lock-up applies for six months from issuance date of each tranche.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.